Literature DB >> 2897308

Direct application of a guanylate cyclase activator lowers intraocular pressure.

J A Nathanson1.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 2897308     DOI: 10.1016/0014-2999(88)90648-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  6 in total

1.  Basal nitric oxide production is enhanced by hydraulic pressure in cultured human trabecular cells.

Authors:  T Matsuo
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Nitric oxide synthase activity in tissues of the bovine eye.

Authors:  O Geyer; S M Podos; T Mittag
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-12       Impact factor: 3.117

3.  Episcleral venous pressure responses to topical nitroprusside and N-Nitro-L-arginine methyl ester.

Authors:  David O Zamora; Jeffrey W Kiel
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-29       Impact factor: 4.799

4.  Characterization of intraocular pressure responses of the Tibetan monkey (Macaca thibetana).

Authors:  Guo Liu; Tao Zeng; Wenhan Yu; Naihong Yan; Hongxing Wang; Su-ping Cai; Iok-Hou Pang; Xuyang Liu
Journal:  Mol Vis       Date:  2011-05-27       Impact factor: 2.367

Review 5.  Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma.

Authors:  Emmanuel S Buys; Lincoln R Potter; Louis R Pasquale; Bruce R Ksander
Journal:  Front Mol Neurosci       Date:  2014-05-19       Impact factor: 5.639

Review 6.  The Application of Nitric Oxide for Ocular Hypertension Treatment.

Authors:  Binze Han; Maomao Song; Liping Li; Xinghuai Sun; Yuan Lei
Journal:  Molecules       Date:  2021-12-01       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.